These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 31210289)
1. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression. Yao N; Sun JQ; Yu L; Ma L; Guo BQ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289 [TBL] [Abstract][Full Text] [Related]
2. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer. Ma SY; Wei P; Qu F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo. Zeng S; Liu S; Feng J; Gao J; Xue F Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway. Zhuang XH; Liu Y; Li JL Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118 [TBL] [Abstract][Full Text] [Related]
6. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis. Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282 [TBL] [Abstract][Full Text] [Related]
7. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. Fang YN; Huang ZL; Li H; Tan WB; Zhang QG; Wang L; Wu JL Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5127-5133. PubMed ID: 30178832 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway. Zhao J; Liu HR Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076 [TBL] [Abstract][Full Text] [Related]
9. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway. Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p. Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987 [TBL] [Abstract][Full Text] [Related]
11. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer. Xu JH; Wang Y; Xu D Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074 [TBL] [Abstract][Full Text] [Related]
12. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression. Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer. Yang X; Xu L; Yang YE; Xiong C; Yu J; Wang Y; Lin Y J Ovarian Res; 2020 Aug; 13(1):100. PubMed ID: 32862831 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838 [TBL] [Abstract][Full Text] [Related]
15. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression. Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821 [TBL] [Abstract][Full Text] [Related]
16. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872 [TBL] [Abstract][Full Text] [Related]
17. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1. Gong YB; Fan XH Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161 [TBL] [Abstract][Full Text] [Related]
18. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
19. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression. Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]